Precision Neuroscience gains FDA approval for BCI device within 2 yea…

Market overview

Precision Neuroscience will receive FDA approval for its brain-computer interface device by May 2028, following the Medtronic partnership and accelerated clinical trials. Regulatory clearance will unlock commercial sales and partnerships with Medtronic.

regulatory prediction market

Implied probability (Yes)

60%

Source: user-generated

More regulatory markets

• Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
• Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
• Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
• Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
• Harborne crypto holdings face regulatory scrutiny — 60% Yes
• SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
• SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
• Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes

Browse all regulatory markets →